REVISITING GVL EFFECT OF AZACITIDINE TREATMENT IN RELAPSED MDS PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

被引：0
|
作者：
Cho, S. G. [1 ]
Kim, S. Y. [1 ]
Cho, B. S. [1 ]
Kim, M. [1 ]
Eom, K. S. [1 ]
Kim, Y. J. [1 ]
Kim, H. J. [1 ]
Lee, S. [1 ]
Min, C. K. [1 ]
Kim, D. W. [1 ]
Lee, J. W. [1 ]
Min, W. S. [1 ]
Park, J. W. [1 ]
Kim, C. C. [1 ]
机构：
[1] Catholic Univ Korea, Seoul, South Korea
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0700
引用
收藏
页码：281 / 281
页数：1
相关论文
共 50 条
  • [21] Quantitative chimerism kinetics in relapsed leukemia patients after allogeneic hematopoietic stem cell transplantation
    QIN XiaoyingLI GuoxuanQIN YazhenWANG YuWANG FengrongLIU DaihongXU LanpingCHEN Huan HAN WeiWANG JingzhiZHANG XiaohuiLI JinlanLI LingdiLIU Kaiyan and HUANG Xiaojun Peking University Peoples HospitalPeking University Institute of HematologyBeijing Key Laboratory of Hematopoietic Stem Cell TransplantationBeijing China
    中华医学杂志（英文版）, 2012, (11) : 1952 - 1959
  • [22] Allogeneic hematopoietic cell transplantation (HCT) for myelodysplastic syndrome (MDS) after pretransplant 5-azacitidine
    Field, Teresa
    Alsina, Melissa
    Ayala, Ernesto
    Fernandez, Hugo
    Janssen, William
    Karfan-Dabaja, Mohammed
    Lancer, Jeffery
    Melchert, Mafda
    Raychaudhuri, Jyoti
    Sullivan, Daniel
    List, Alan
    Anasetti, Claudio
    Poling, William
    Perkins, Janelle
    BLOOD, 2007, 110 (11) : 338B - 338B
  • [23] 5-azacitidine in combination with donor lymphocyte infusions for the treatment of patients with MDS or AML relapsing after allogeneic stem cell transplantation
    Czibere, A.
    Graef, T.
    Bruns, I.
    Zohren, F.
    Germing, U.
    Haas, R.
    Kobbe, G.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S64 - S64
  • [24] Allogeneic Hematopoietic Stem Cell Transplantation: A Salvage Treatment for Relapsed or Refractory Lymphoma
    Wang, Jing-Shi
    Wang, Zhao
    Wang, Yi-Ni
    Wu, Lin
    Fu, Li
    Wei, Na
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2015, 31 (04) : 426 - 433
  • [25] Allogeneic Hematopoietic Stem Cell Transplantation: A Salvage Treatment for Relapsed or Refractory Lymphoma
    Jing-Shi Wang
    Zhao Wang
    Yi-Ni Wang
    Lin Wu
    Li Fu
    Na Wei
    Indian Journal of Hematology and Blood Transfusion, 2015, 31 : 426 - 433
  • [26] Limited benefit in patients with MDS receiving venetoclax and azacitidine as a bridge to allogeneic stem cell transplantation
    Jadersten, Martin
    Boriskina, Ksenia
    Lindholm, Carolin
    Westrom, Simone
    Cavelier, Lucia
    Hellstrom-Lindberg, Eva
    Mielke, Stephan
    Tobiasson, Magnus
    LEUKEMIA & LYMPHOMA, 2022, 63 (03) : 755 - 758
  • [27] Treatment Outcomes and Prognostic Factors of Patients with Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
    Choi, Yunsuk
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Park, Han-Seung
    Choi, Eunji
    Ko, Sun-Hye
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Lee, Je-Hwan
    BLOOD, 2016, 128 (22)
  • [28] Prognostic Effect of ASXL1 Mutations in Patients with MDS and Secondary AML Following MDS After Allogeneic Hematopoietic Stem Cell Transplantation
    Koenecke, Christian
    Thol, Felicitas
    Loeffeld, Patrick
    Buchholz, Stefanie
    Stadler, Michael
    Goehring, Gudrun
    Dammann, Elke
    Kleine, Moritz
    Brauns, Wiebke
    Hallensleben, Michael
    Schmidtke, Joerg
    Schlegelberger, Brigitte
    Krauter, Juergen
    Ganser, Arnold
    Heuser, Michael
    BLOOD, 2011, 118 (21) : 744 - 745
  • [29] Maintenance Therapy with Low-Dose Azacitidine (AZA) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Relapsed or Refractory AML or MDS: A Dose and Schedule Finding Study
    De Lima, Marcos
    Silva, Leandro de Padua
    Giralt, Sergio
    Komanduri, Krishna
    Andersson, Borje S.
    Hosing, Chitra
    Qazilbash, Muzaffar
    Shpall, Elizabeth
    Thall, Peter
    Zhang, Weiqing
    McCormick, Gloria
    Wang, Xuemei
    Popat, Uday
    Soriano, Andres
    Alousi, Amin
    Champlin, Richard
    Garcia-Manero, Guillermo
    BLOOD, 2008, 112 (11) : 414 - 414
  • [30] The outcome of DLI in AML/MDS patients relapsed after allogeneic stem cell transplantation: multicentre retrospective study
    Moon, J. H.
    Sohn, S. K.
    Kim, J. G.
    Chae, Y. S.
    Cho, Y. Y.
    Ahn, J. S.
    Yang, D. H.
    Lee, J. J.
    Kim, H. J.
    Choi, Y. J.
    Shin, H. J.
    Jung, J. S.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S431 - S432
12345